Modulation of apoptosis by herpesviruses

Seminars in Virology

Volumn 8, Issue 6, 1998, Pages 471-480

  Kieff, Elliott ^a   Shenk, Thomas ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b PRINCETON UNIVERSITY   (United States)

Author keywords

Apoptosis; Cytomegalovirus; Epstein Barr virus; Herpes simplex virus; Programmed cell death

Indexed keywords

FAS ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; HERPES SIMPLEX VIRUS; HERPES VIRUS; HUMAN; MODULATION; REVIEW; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0031757469     PISSN: 10445773     EISSN: None     Source Type: Journal    
DOI: 10.1006/smvy.1998.0151     Document Type: Article

References (94)

1. Roizman B. The family herpes viridae: A brief introduction. The Human Herpesviruses. 1993;Raven Press, New York.
2. Tropea F., Troiano L., Monti D., Lovato E., Malorni W., Rainaldi G., Mattana P., Viscomi G., Ingletti M. C., Portolani M., Cermelli C., Cossarizza A., Franceschi C. Sendai and herpes virus type 1 induce apoptosis in human peripheral blood mononuclear cells. Expt. Cell Res. 218:1995;63-70.
3. Ito M., Watanabe M., Kamiya H., Sakurai M. Herpes simplex virus type 1 induces apoptosis in peripheral blood T lymphocytes. J. Infect. Dis. 175:1997;1220-1224.
4. Griebel P. J., Ohmann H. B., Lawman M. J. P., Babiuk L. A. The interaction between bovine herpesvirus type 1 and activated bovine T lymphocytes. J. Gen. Virol. 71:1990;369-377.
5. Sadzot-Delvaux C., Thonard P., Schoonbroodt S., Piette J., Rentier B. Varicella-zoster virus induces apoptosis in cell culture. J. Gen. Virol. 76:1995;2875-2879.
6. Hammer S. M., Carney W. P., Iacoviello V. R., Lowe B. R., Hirsch M. S. Herpes simplex virus infection of human T cell subpopulations. Infect. Immun. 38:1982;795-797.
7. Hanon E., Vanderplasschen A., Lyaku J., Keil G., Denis M., Pastoret P.-P. Inactivated bovine herpesvirus 1 induces apoptotic cell death of mitogen-stimulated bovine peripheral blood mononuclear cells. J. Virol. 70:1996;4116-4120.
8. Montgomery R. I., Warner M. S., Lum B. J., Spear P. G. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell. 87:1996;427-436.
9. Whitbeck J. C., Peng C., Lou H., Xu R., Willis S. H., Ponce de Leon M., Peng T., Nicola A. V., Montgomery R. I., Warner M. S., Soulika A. M., Spruce L. A., Moore W. T., Lambris J. D., Spear P. G., Cohen G. H., Eisenberg R. J. Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry. J. Virol. 71:1997;6083-6093.
10. ++. J. Gen. Virol. 68:1987;825-833.
11. +-. J. Immunol. 140:1988;3610-3616.
12. 1. Science. 250:1990;1262-1266.
13. 1. Proc. Natl. Acad. Sci. USA. 89:1992;3266-3270.
14. He B., Chou J., Liebermann D. A., Hoffman B., Roizman B. The carboxyl terminus of the murine MyD116 gene substitutes for the corresponding domain of the gamma (1)34.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells. J. Virol. 70:1996;84-90.
15. -. Proc. Natl. Acad. Sci. USA. 92:1995;10516-10520.
16. He B., Gross M., Roizman B. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1 alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA. 94:1997;843-848.
17. Duke R. C., Cohen J. J. IL-2 addiction: Withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res. 5:1986;289-299.
18. Johnson E. M. Jr., Chang J. Y., Koike T., Martin D. P. Why do neurons die when deprived of trophic factor. Neurobiol. Aging. 10:1989;549-552.
19. Lee S. B., Esteban M. The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology. 199:1994;491-496.
20. Kibler K. V., Shors T., Perkins K. B., Zeman C. C., Banazak M. P., Biesterfeldt J., Langland J. O., Jacobs B. L. Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. J. Virol. 71:1997;1992-2003.
21. Zhan Q., Lord K., Alamo I., Hollander M., Carrier F., Ron D., Kohn K., Hoffman B., Lieberman D., Furnace A. The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol. Cell Biol. 14:1994;2361-2371.
22. Coffin R. S., MacLean A. R., Latchman D. S., Brown S. M. Gene delivery to the central and peripheral nervous systems of mice using HSV1 ICP34.5 deletion mutant vectors. Gene Ther. 3:1996;886-891.
23. Koyama A. H., Miwa Y. Suppression of apoptotic DNA fragmentation in herpes simplex virus type 1-infected cells. J. Virol. 71:1997;2567-2571.
24. Leopardi R., Van Sant C., Roizman B. The herpes simplex virus 1 protein kinase Us3 is required for protection from apoptosis induced by the virus. Proc. Natl. Acad. Sci. USA. 94:1997;7891-7896.
25. Sieg S., Yildirim Z., Smith D., Kayagaki N., Yagita H., Huang Y., Kaplan D. Herpes simplex virus type 2 inhibition of Fas ligand expression. J. Virol. 70:1996;8747-8751.
26. Sieg S., Huang Y., Kaplan D. Viral regulation of CD95 expression and apoptosis in T lymphocytes. J. Immunol. 159:1997;1192-1199.
27. Sing G. K., Ruscetti F. W. Preferential suppression of myelopoiesis in normal human bone marrow cells after in vitro challenge with human cytomegalovirus. Blood. 75:1990;1965-1973.
28. Maciejewski J. P., Bruening E. E., Donahue R. E., Mocarski E. S., Young N. S., St. Jeor S. C. Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood. 80:1992;170-178.
29. Simmons P., Kaushansky K., Torok-Storb B. Mechanisms of cytomegalovirus-mediated myelosuppression: Perturbation of stromal cell function versus direct infection of myeloid cells. Proc. Natl. Acad. Sci. USA. 87:1990;1386-1390.
30. Lagneaux L., Delforge A., Snoeck R., Stryckmans P., Bron D. Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells. Exp. Hematol. 22:1994;26-30.
31. Mutter W., Reddehase M. J., Busch F. W., Buhring H.-J., Koszinowski U. H. Failure in generating hematopoietic stem cells is the primary cause of death in their immunocompromised host. J. Exp. Med. 167:1988;1645-1658.
32. Gibbons A. E., Price P., Shellam G. R. Analysis of hematopoietic stem and progenitor cell population in cytomegalovirus-infected mice. Blood. 86:1995;473-481.
33. Mori T., Ando K., Tanaka K., Ikeda Y., Koga Y. Fas-mediated apoptosis of the hematopoietic progenitor cells in mice infected with murine cytomegalovirus. Blood. 89:1997;3565-3573.
34. Selgrade M. K., Ahmed A., Sell K. W., Gershwin M. E., Steinberg A. D. Effect of murine cytomegalovirus on the in vitro responses of T and B cells to mitogens. J. Immunol. 116:1976;1459-1465.
35. Loh L., Hudson J. B. Immunosuppressive effect of murine cytomegalovirus. Infect. Immun. 27:1980;54-60.
36. Allan J. E., Shellam G. R., Grundy J. E. Effect of murine cytomegalovirus on mitogenic responses in genetically resistant and susceptible mice. Infect. Immun. 36:1982;235-242.
37. Osborn J. E., Blazkovec A. A., Walker D. N. Immunosuppression during acute murine cytomegalovirus infection. J. Immunol. 100:1968;835-844.
38. Campbell A. E., Slater J. S., Futch W. S. Murine cytomegalovirus-induced suppression of antigen-specific cytotoxic T lymphocyte maturation. Virology. 173:1989;268-275.
39. Slater J. S., Futch W. S., Cavanaugh V. J., Campbell A. E. Murine cytomegalovirus independently inhibits priming of helper and cytotoxic T lymphocytes. Virology. 185:1991;132-139.
40. Carney W., Hirsch M. Mechanisms of immunosuppression in cytomegalovirus mononucleosis. II. Virus-monocyte interactions. Infect. Dis. 144:1981;47-54.
41. Rinaldo C. R. J., Ho M., Homoude W. H., Gui X. E., DeBiasio R. L. Lymphocyte subsets and natural killer cell responses during cytomegalovirus mononucleosis. Infect. Immun. 40:1983;472-477.
42. Brideau R. J., Nicholas J. A. W. Pyrimidinone (bropirimine) mediated alteration of T lymphocyte subsets during murine cytomegalovirus infection. Clin. Exp. Immunol. 68:1987;613-620.
43. Yoshida H., Sumichika H., Hamano S., He X., Minamishima Y., Kimura G., Nomoto K. Induction of apoptosis of T cells by infecting mice with murine cytomegalovirus. J. Virol. 69:1995;4769-4775.
44. Koga Y., Tanaka K., Lu Y. Y., Oh T. M., Sasaki M., Kimura G., Nomoto K. Priming of immature thymocytes to CD3-mediated apoptosis by infection with murine cytomegalovirus. J. Virol. 68:1994;4322-4328.
45. Inoue Y., Yasukawa M., Fujita S. Induction of T-cell apoptosis by human herpesvirus 6. J. Virol. 71:1997;3751-3759.
46. Zhu H., Shen Y., Shenk T. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol. 69:1995;7960-7970.
47. Rao L., Debbas M., Sabbatini P., Hockenbery D., Korsmeyer S., White E. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA. 89:1992;7742-7746.
48. Mocarski E. S. Cytomegaloviruses and their replication. Fields B. N., Knipe D. M., Howley P. M. Fields Virology. 1996;Lippincott-Raven, Philadelphia.
49. Yurochko A. D., Kowalik T. F., Huong S. M., Huang E. S. Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J. Virol. 69:1995;5391-5400.
50. Rickinson A., Kieff E. Epstein-Barr virus. Fields B. N., Knipe D. M., Howley P. M. Fields Virology. 1996;Lippincott-Raven, Philadelphia.
51. Kieff E. Epstein-Barr virus and its replication. Fields B. N., Knipe D. M., Howley P. M. Fields Virology. 1996;Lippincott-Raven, Philadelphia.
52. Martin J. M., Veis D., Korsmeyer S. J., Sugden B. Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2. J. Virol. 67:1993;5269-5278.
53. Cherney B. W., Bhatia K., Tosato G. A role for deregulated c-Myc expression in apoptosis of Epstein-Barr virus-immortalized B cells. Proc. Natl. Acad. Sci. USA. 91:1994;12967-12971.
54. Cutrona G., Ulivi M., Fais F., Roncella S., Ferrarini M. Transfection of the c-myc oncogene into normal Epstein-Barr virus-harboring B cells results in new phenotypic and functional features resembling those of Burkitt lymphoma cells and normal centroblasts. J. Exp. Med. 181:1995;699-711.
55. Allday M. J., Sinclair A., Parker G., Crawford D. H., Farrell P. J. Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53. EMBO J. 14:1995;1382-1391.
56. Kawanishi M. Epstein-Barr virus induces fragmentation of chromosomal DNA during lytic infection. J. Virol. 67:1993;7654-7658.
57. Mannick J. B., Asano K., Izumi K., Kieff E., Stamler J. S. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell. 79:1994;1137-1146.
58. Gregory C. D., Dive C., Henderson S., Smith C. A., Williams G. T., Gordon J., Rickinson A. B. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature. 349:1991;612-614.
59. Henderson S., Huen D., Rowe M., Dawson C., Johnson G., Rickinson A. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA. 90:1993;8479-8483.
60. Rowe M., Peng P. M., Huen D. S., Hardy R., Croom C. D., Lundgren E., Rickenson A. B. Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: A B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers. J. Virol. 69:1994;5602-5612.
61. Okan I., Wang Y., Chen F., Hu L. F., Imreh S., Klein G., Wiman K. G. The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest. Oncogene. 11:1995;1027-1031.
62. Laherty C. D., Hu H. M., Opipari A. W., Wang F., Dixit V. M. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J. Biol. Chem. 267:1992;24157-24160.
63. Huen D. S., Henderson S. A., Croom C. D., Rowe M. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene. 10:1995;549-560.
64. Mitchell T., Sugden B. Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J. Virol. 69:1995;2968-2976.
65. Tomkinson B., Kieff E. Use of second site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein EBNA-3B is not important for B-lymphocyte infection or growth transformation in vitro. J. Virol. 66:1992;2893-2903.
66. Silins S. L., Sculley T. B. Burkitt's lymphoma cells are resistant to programmed cell death in the presence of the Epstein-Barr virus latent antigen EBNA-4. Int. J. Cancer. 60:1995;65-72.
67. Fries K. L., Miller W. E., Raab-Traub N. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J. Virol. 70:1996;8653-8659.
68. Kawanishi M. Anti-apoptotic function of the Epstein-Barr virus LMP1 and BHRF1 proteins. Nippon Rinsho. 54:1996;1848-1854.
69. Kaye K., Izumi K., Mosialos G., Kieff E. The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B lymphocyte transformation: Fibroblast co-cultivation complements a critical function within the terminal 155 residues. J. Virol. 69:1995;675-683.
70. Izumi K., Kieff E. The Epstein-Barr virus oncogene LMP1 engages TRADD to mediate B lymphocyte growth transformation and activate NF-κB. Proc. Natl. Acad. Sci. USA. 94:1997;12592-12597.
71. Mosialos G., Birkenbach M., Yalamanchili R., VanArsdale T., Ware C., Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell. 80:1995;389-399.
72. Devergne O., Hatzivasilliou E., Izumi K., Kaye K., Kleijnen M., Kieff E., Mosialos G. TRAF1, TRAF2, and TRAF3 effect NF-κB activation by an Epstein-Barr virus LMP1 domain important for B lymphocyte transformation. Mol. Cell. Biol. 16:1996;7098-7108.
73. Kaye K., Devergne O., Harada J., Izumi K., Kieff E., Mosialos G. TNF receptor associated factor 2 (TRAF2) is a mediator of NFκB activation by the Epstein-Barr virus transforming protein LMP1. Proc. Natl. Acad. Sci. USA. 93:1996;11085-11090.
74. Sandberg M., Hammerschmidt W., Sugden B. Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. J. Virol. 71:1997;4649-4656.
75. Izumi K., Kaye K., Kieff E. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA. 94:1997;1447-1452.
76. Beg A. A., Baltimore D. An essential role of NF-κB in preventing TNF-α-induced cell death. Science. 274:1996;782-784.
77. Wang C. Y., Mayo M. W., Baldwin S. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science. 274:1996;784-787.
78. Van Antwerp D. J., Martin S. J., Kafri T., Green D. R., Verma I. M. Suppression of TNF-α-induced apoptosis by NF-κB. Science. 274:1996;787-789.
79. Miller W., Mosialos G., Kieff E., Raab-Traub N. Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-κB. J. Virol. 71:1997;586-594.
80. Hatzivassiliou E., Miller W., Raab-Traub N., Kieff E., Mosialos G. A fusion of the Epstein-Barr virus latent membrane protein 1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 inconstitutive activation of epidermal growth factor receptor expression, nuclear factor κB, and stress activated protein kinase. J. Immunol. 160:1998;1116-1121.
81. Hilberg F., Aguzzi A., Howells N., Wagner E. c-Jun is essential for normal mouse development and hepatogenesis. Nature. 365:1993;179-181.
82. Pearson G., Luka J., Petti L., Sample J., Birkenbach M., Braun D., Kieff E. Identification of an Epstein-Barr virus early gene encoding for a second component of the restricted early antigen complex. Virology. 160:1987;151-161.
83. Cleary M. L., Smith S. D., Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell. 47:1986;19-28.
84. Murray P. G., Swinnen L. J., Constandinou C. M., Pyle J. M., Carr T. J., Hardwick J. M., Ambinder R. F. BCL-2 but not its Epstein-Barr virus-encoded homologue, BHRF1, is commonly expressed in posttransplantation lympho proliferative disorders. Blood. 87:1996;706-711.
85. Marchini A., Tomkinson B., Cohen J., Kieff E. BHRF1, the Epstein-Barr virus gene with homology to Bcl2, is dispensable for B-lymphocyte transformation and virus replication. J. Virol. 65:1991;5991-6000.
86. McCarthy N. J., Hazlewood S. A., Huen D. S., Rickinson A. B., Williams G. T. The Epstein-Barr virus gene BHRF1, a homologue of the cellular oncogene Bcl-2, inhibits apoptosis induced by gamma radiation and chemotherapeutic drugs. Adv. Exp. Med. Biol. 406:1996;83-97.
87. Theodorakis P., D'Sa-Eipper C., Subramanian T., Chinnadurai G. Unmasking of a proliferation-restraining activity of the anti-apoptosis protein EBV BHRF1. Oncogene. 12:1996;1707-1713.
88. Dawson C. W., Eliopoulos A. G., Dawson J., Young L. S. BHRF1, a viral homologue of the Bcl-2 oncogene, disturbs epithelial cell differentiation. Oncogene. 10:1995;69-77.
89. Kawanishi M. Epstein-Barr virus BHRF1 protein protects intestine 407 epithelial cells from apoptosis induced by tumor necrosis factor alpha and anti-Fas antibody. J. Virol. 71:1997;3319-3322.
90. Nava V. E., Cheng E. H., Veliuona M., Zou S., Clem R. J., Mayer M. L., Hardwick J. M. Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene. J. Virol. 71:1997;4118-4122.
91. Cheng E. H., Nicholas J., Bellows D. S., Hayward G. S., Guo H. G., Reitz M. S., Hardwick J. M. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc. Natl. Acad. Sci. USA. 94:1997;690-694.
92. Bertin J., Armstrong R. C., Ottilie S., Martin D. A., Wang Y., Banks S., Wang G. H., Senkevich T. G., Alnemri E. S., Moss B., Lenardo M. J., Tomaselli K. J., Cohen J. I. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA. 94:1997;1172-1176.
93. Thome M., Schneider P., Hofmann K., Fickenscher H., Meinl E., Neipel F., Mattmann C., Burns K., Bodmer J. L., Schroter M., Scaffidi C., Krammer P. H., Peter M. E., Tschopp J. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature. 386:1997;517-521.
94. Hu S., Vincenz C., Buller M., Dixit V. M. A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis. J. Biol. Chem. 272:1997;9621-9624.